A. Iliukhina

SERS-Based Aptasensor for Rapid Quantitative Detection of SARS-CoV-2

A. Arutyunyan, A. Gambaryan, V. Gushchin, 2021, Nanomaterials.

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates

A. Gintsburg, D. Logunov, B. Naroditsky, 2022, Emerging microbes & infections.

Simple ELISA Methods to Estimate Neutralizing Antibody Titers to SARS-CoV-2: IgG Quantification, the Avidity Index, and the Surrogate Virus Neutralization Test

A. Tkachuk, I. Dolzhikova, A. Iliukhina, 2022, Archives of Microbiology & Immunology.

Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus

E. D. Belyaeva, V. Gushchin, I. Grigoriev, 2022, Frontiers in Immunology.

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern

O. Voronina, M. Kunda, N. Ryzhova, 2021, bioRxiv.

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants

A. Shchetinin, V. Gushchin, O. Voronina, 2021, Vaccines.

Sputnik Light booster after Sputnik V vaccination induces robust neutralizing antibody response to B.1.1.529 (Omicron) SARS-CoV-2 variant

V. Gushchin, F. Izhaeva, A. Tukhvatulin, 2021, medRxiv.

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19

A. Gintsburg, D. Logunov, B. Naroditsky, 2023, Frontiers in Immunology.

Specifics of mathematical modeling of erosion of structures made out of different materials by high-speed hydro-abrasive water jet

V. Kolpakov, A. Iliukhina, 2019, XLIII ACADEMIC SPACE CONFERENCE: dedicated to the memory of academician S.P. Korolev and other outstanding Russian scientists – Pioneers of space exploration.

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study

V. Gushchin, A. Gintsburg, D. Logunov, 2023, Frontiers in immunology.

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1

D. Logunov, A. Siniavin, I. Dolzhikova, 2023, Vaccines.